
Altamira Therapeutics Investor Relations Material
Latest events

H1 2024
Altamira Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Altamira Therapeutics Ltd
Access all reports
Altamira Therapeutics Ltd is a Switzerland-based biopharmaceutical company focused on developing and commercializing therapies for ear, nose, and throat (ENT) and central nervous system (CNS) disorders. The company's pipeline includes RNA-based therapeutics, as well as treatments for inner ear conditions such as tinnitus and vertigo. Altamira Therapeutics applies its proprietary delivery platforms to target therapeutic molecules effectively, aiming to address unmet medical needs across its key treatment areas. The company is headquartered in Hamilton, Bermuda, and its shares are listed on the NASDAQ.
Key slides for Altamira Therapeutics Ltd


Corporate Presentation
Altamira Therapeutics Ltd


Corporate Presentation
Altamira Therapeutics Ltd
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
CYTO
Country
🇺🇸 United States